Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001569926-26-000002

Chief Executive Officer acquired 1,008,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nolan Sean P. · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-12 Grant or award : show line 1 in the form +1,008,000 3,086,358 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-12 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +648,000 648,000 D
Loading xslF345X05/form4-01142026_040103.xml…